Neonatal hyperglycemia after acetazolamide therapy for hydrocephalus in extremely low birth weight infants

Hyperglycemia is a common complication of extremely low birth weight infants (ELBW) which may have an impact upon their morbidity and mortality. Hyperglycemia in ELBW can occurred as result of many factors. We report a rare case of hyperglycemia in an ELBW infant after administration of a carbonic anhydrase inhibitor (acetazolamide), used for temporary management of posthemorrhagic hydrocephalus, our case was seen in one of the private hospital at Dammam city, Saudi Arabia.